Azenta to acquire B Medical Systems for €410M cash plus €50M earnout

Azenta, Inc.

Cash purchase price €410M; up to €50M additional contingent consideration based on performance milestones.
B Medical generated ~€109M revenue in last twelve months ending June 30, 2022.
Transaction expected to close in October 2022, subject to customary conditions.
Acquisition expected to be accretive to non-GAAP earnings in FY2023 and GAAP earnings in FY2024.
B Medical CEO Luc Provost and Deputy CEO Jesal Doshi expected to remain with Azenta.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.